between in Biological Technology

Statement From Michael Hansen, CEO of Elsevier's Health Sciences Division, Regarding Australia Based Sponsored Journal Practices Between 2000 and 2005

PHILADELPHIA, Pennysylvania, May 7 /PRNewswire-FirstCall/ -- Elsevier, one of the world's leading publishers of scientific, technical, and medical (STM) information products and services, announced today that Michael Hansen, CEO of Elsevier's Health Sciences Division, issued the following stat...

Forward-Thinking Patient Recruitment Company Poised to Create Bridges Between Japanese Clinical R&D Industry and Global Clinical Trial Marketplace

Establishing Wholly-owned Subsidiary to Enable BBK Worldwide to Better Serve Asia-Pacific Clinical Trial Enrollment Concerns NEWTON, Mass., March 18 /PRNewswire/ -- BBK Worldwide, a global leader in patient recruitment for clinical trials, has announced the opening of BBK Worldwide -- Osaka, ...

UPDATE: OPC Connectivity Between TruBio Software and Nova FLEX Analyzers

SANTA CLARA, Calif., March 6 /PRNewswire/ -- Finesse Solutions, LLC, Santa Clara, CA, a manufacturer of measurement and control solutions for bioprocess applications, and Nova Biomedical, Waltham, MA, a world leader in biotechnology process monitoring announced the release of a TruBio(TM) plug-in ...

OPC Connectivity Between TruBio Software and Nova FLEX Analyzers

SANTA CLARA, Calif., March 5 /PRNewswire/ -- Finesse Solutions, LLC, Santa Clara, CA, a manufacturer of measurement and control solutions for bioprocess applications, and Nova Biomedical, Waltham, MA, a world leader in biotechnology process monitoring announced the release of a TruBio(TM) plug-in ...

Controversial Study to Test Link Between Insomnia and Sleep Apnea

Measuring Prevalence of Sleep Apnea Among Insomnia Patients ALBUQUERQUE, N.M., Feb. 9 /PRNewswire/ -- The Sleep and Human Health Institute (SHHI) was awarded a grant to study one of the most controversial aspects of Chronic Insomnia. Conventional wisdom connects insomnia to psychological fact...

Multinational deCODE Study Identifies New Link Between Inflammation and Heart Attack

REYKJAVIK, Iceland, February 9 /PRNewswire-FirstCall/ -- In a paper published today, scientists at deCODE genetics (Nasdaq: DCGN ) and academic colleagues from four continents present a novel insight into the connection between inflammation and heart disease. Through a genome-wide search in s...

MedTechIQ Selects TheBrain to Visualize Expansive Biointellingence Database and Connect the Dots Between Life Sciences, Medicine and Venture Capital

TheBrain's dynamic interface enhances Web community and presence by visualizing vast networks of information and deepening understanding of content. Marina del Rey, CA (PRWEB) October 23, 2008 -- TheBrain® Technologies, the leading provider visualization software, a...

Core Laboratories Joint Venture Agreement Between genae associates, VIBGYOR Scientific Research, Cardiovascular Center Aalst and J.B. Dahm

ANTWERP and AALST , Belgium, AHMEDABAD, India and GOTTINGEN, Germany, October 6 /PRNewswire/ -- VIBGYOR Scientific Research, genae associates, Cardiovascular Center Aalst and J.B. Dahm, MD have reached an agreement to form a Core Laboratories joint venture, called imaeon. imaeon initially wi...

Half of Surveyed Physicians Expect to Replace Between 6 Percent and 15 Percent of Their Sustiva Prescriptions with Isentress

Most Surveyed MCO Pharmacy Directors Do Not Place Cost Control Measures on Branded Antiretroviral Drugs, According to a New Report from Decision Resources WALTHAM, Mass., Aug. 26 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisor...

Bion Outlines Differences between its Patented Comprehensive Livestock Environmental Treatment Technology and Anaerobic Digesters

NEW YORK, June 23 /PRNewswire-FirstCall/ -- Bion Environmental Technologies, Inc. (OTC Bulletin Board: BNET) today outlined the capabilities and performance of its comprehensive livestock environmental treatment technology compared to anaerobic digesters. Anaerobic or methane digestion (AD) ...

IDF Urges Healthcare Providers to Address the Relationship Between Type 2 Diabetes and Sleep Apnea

Treating These Closely-Related Conditions Requires New Clinical Practices and Research to Reduce Personal and Public Health Costs SAN FRANCISCO and BRUSSELS, June 7 /PRNewswire/ -- The International Diabetes Federation (IDF) Task Force on Epidemiology and Prevention warned today that rec...

DolmatConnell & Partners 2008 Studies of CEO and CFO Compensation in the 100 Largest High Technology and Life Science Companies Show Dramatically Improving Link Between Pay and Performance

BOSTON, May 21 /PRNewswire/ -- DolmatConnell and Partners released our 2008 studies of executive compensation in the Tech100 and LifeScience100 (the studies are available for download at ( http://www.dolmatconnell.com ) today and issued the below press release that we wanted to ensure that you...

New Fragment-based Drug Discovery Platform Announced Between IOTA Pharmaceuticals Ltd, Cambridge (UK), and Beactica AB, Uppsala (Sweden)

UPPSALA, Sweden and CAMBRIDGE, England, April 23 /PRNewswire/ -- Two leading companies in the area of fragment-based drug discovery (FBDD) today announced a new commercial alliance. IOTA Pharmaceuticals Ltd, based in Cambridge, UK, and Beactica AB, based in Uppsala, Sweden, will join forces to...

ES Vascular Receives CE Mark for its First Aortic Stapler for End-to-End Anastomosis Between Synthetic Grafts and Aorta During Open Repair of Aortic Aneurysmal and Occlusive Disease

HAIFA, Israel, April 14 /PRNewswire/ -- ES Vascular Ltd. announced today that it has received a CE Mark approval for its Open Aortic Stapler (OAS) system for mechanical suturing technology of aortic synthetic grafts during open repair of AAA and other aortic reconstructions, enabling commercia...

deCODE Discovers Gene Variants that May Help to Distribute the Work of Evolution between Men and Women

REYKJAVIK, Iceland, Jan. 31 /PRNewswire-FirstCall/ -- Scientists from deCODE genetics (Nasdaq: DCGN ) today report the discovery of two common, single-letter variants in the sequence of the human genome (SNPs) that regulate one of the principle motors of evolution. Versions of the two SNPs, l...

PCAS : Tighter Links Between PCAS and Proteus

LONGJUMEAU, France, October 22 /PRNewswire-FirstCall/ -- Proteus today announced the completion of a share capital increase reserved for Proteus' industrial partner PCAS. PCAS' stake in Proteus now represents 32% of the issued share capital vs 6% before the increase. Proceeds of this private p...

'Alliance for Medical Devices, Instrumentation and Diagnostics' formed between Fraunhofer Center for Manufacturing Innovation and Boston University

PLYMOUTH, Mich., Sept. 10 /PRNewswire/ -- The primary objective of the Alliance is to improve patient care by accelerating the delivery of biomedical advances to the marketplace. To celebrate the Alliance, a symposium was held at Boston University on Friday, September 7th with noted speakers ...

Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court

ANNAPOLIS, Md., Aug. 13 /PRNewswire-FirstCall/ -- PharmAthene, Inc., (Amex: PIP ) a biodefense company developing and commercializing medical countermeasures against biological and chemical threats, announced today that proceedings have been initiated with the Delaware Chancery Court to affir...

Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.

ANNAPOLIS, Md., Aug. 17 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: PIP ) announced today that a hearing has been scheduled by the Delaware Court of Chancery for 2:00 p.m. on Monday, August 27, 2007, in an action filed by PharmAthene stockholder Matthew P. Kinley pursuant to Section 22...

Japan, Midwest Biotechnology Industry Leaders Identify Steps for Greater Collaboration Between Countries

CHICAGO,IL--Top industry, government and academic leaders in the biotech and life science industries from the Midwest U.S. and Japan gathered Wednesday in Chicago as part of the JETRO Midwest-Japan Biotechnology Summit. The topics covered similarity of challenges faced by Midwest Biotech compan...

How to tackle the divide between techies and non-techies at work

When you work among techies, you learn a lot of things. You learn that most of them are pessimistic about the upcoming film The Hitchhikers Guide to the Galaxy and their faithfulness to the book. As a rule, you learn that techies like Linux and hate Microsoft. Among many other useful things, you...

Feuds between UW and the Legislature should end for good of the state

In Minnesota these days, the governor and the Legislature are bogged down in a budget fight, just like their counterparts in Wisconsin. Money is tight, just as it is in Wisconsin. But there's an important distinction between the two states: In Minnesota, the university budget is one of the few ar...

Line between big pharma, big biotech continues to blur

In our last two columns, we looked at both the magnitude of Big Pharma and the converging trends to create the growth of Specialty Pharma particularly in the U.S. market. We also explored the growth of not only blockbuster drugs (drugs that sell $1 billion or more) but the super-blockbuster dr...

Single gene controls key difference between maize and its wild ancestor

Madison, Wis. -- One of the greatest agricultural and evolutionary puzzles is the origin of maize -- and part of the answer may lie in a plot of corn on the western edge of Madison, where a hybrid crop gives new life to ancient genetic material. While many biologists argue that teosinte, a wil...

Comparison of Performance between the AlphaQuest - HTS and the Fusion α Multilabel Reader for Detection of cAMP

By Laura Gaidar, Kristin Prasauckas, Kelly Carter-Allen and Loraine Upham PerkinElmer Life Sciences, Inc. Introduction AlphaScreen technology is a highly sensitive, non-isotopic homogenous assay method developed for assay development and h...

Monitoring fluorescence resonance energy transfer (FRET) between GFP fusions in lysates of the yeast Saccharomyces cerevisiae using the Varian Cary Eclipse

Monitoring fluorescence resonance energy transfer (FRET) between GFP fusions in lysates of the yeast Saccharomyces cerevisiae using the Varian Cary Eclipse Paul Gavin # and Mark Prescott # , Ph.D Daren J. Fyfe, Ph.D* # Department o...

PCR Performance Comparisons Between pfuturbo and Taq DNA Polymerases

PCR Performance Comparisons Between PfuTurbo and Taq DNA Polymerases pfuturbo DNA polymerase is the superior choice for robust high-fidelity PCR amplification Holly Hogrefe Frances Bai Janice Cline Stratagene In this update, we compare the PCR performan...

DOE awards $377 million in funding for 46 energy frontier research centers

... five years to discover and develop materials that control the interactions between light, electricity, and heat at the nanoscale for improved solar energy con... million for five years to use fundamental knowledge about the interactions between catalysts and plant cell walls to design improved processes for the convers...

Growth spurts

...g dynamic events, and at 300kV the electron beam has enough penetrating power to maintain high resolution, even when looking through a liquid confined between two thin solid windows," says NCEM director Dahmen. "Our resolution is significantly higher than any previous studies of this nature, which made it p...

KV Pharmaceutical Announces Stockholder Action to Amend By-Laws is Invalid

...he possibility that the auction rate securities held by the Company may not return to liquidity at their face value or at all; (21) the consent decree between the Company and the FDA and the Company's suspension of the production and shipment of substantially all of the products that the Company manufactures...

Schering-Plough Shareholders Approve Merger With Merck

... similar words and terms. In particular, forward-looking statements include statements about the timing and potential benefits of the proposed merger between Merck and Schering-Plough; Schering-Plough's and the combined company's strengths; the trending of Schering-Plough's pipeline and business; and other ...

Arizona Pain Specialists Contend Recent Vertebroplasty Studies are Misleading

...procedure had greater reductions in pain, although this was not a statistically significant difference." To demonstrate statistical differences between groups requires that the study have enough patients for the statistics to have sufficient power to detect the differences. Both studies reported that...

AutoImmune Inc. Reports 2009 Second Quarter Financial Results

...ear Phase III trial in patients with secondary progressive multiple sclerosis (SPMS). In addition, there were no statistically significant differences between dirucotide and placebo on the secondary endpoints of the study. Eli Lilly and BioMS also announced that they would discontinue ongoing clinical trial...

GenVec Reports Second Quarter 2009 Financial Results

...sting contracts and collaborations, we anticipate revenues for 2009 will be between $15.0 million and $18.0 million. We project our cash burn to be between $8.0 million and $11.0 million for the 12 months ending June 30, 2010," com...

InterMune Reports Second Quarter 2009 Financial Results and Business Highlights

...ated over 14 days, with no treatment-related serious adverse events (SAEs), dose reductions or discontinuations. There were no drug-drug interactions between the compounds. On April 21, InterMune reported that the INFORM-1 study had been expanded by three additional cohorts to explore the interferon-f...

SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights

...Corp. 2009 Guidance SEQUENOM is updating its 2009 financial guidance as follows: Genetic Analysis : Revenues to range between $32 million and $35 million. Gross margin of approximately 57% in 2009. Net loss of approximately $11 million. Cash burn of breakev...

The Law Offices of Brian D. Witzer Wins 6+ Million Dollar Verdict

...reaction to certain over-the-counter and prescription drugs. SJS is a painful disease and is treated like a burn injury, which can cause skin loss of between 10% and 30% of the total skin surface. TEN is the more severe form of the disease where more than 30% of the body's skin surface is affected and it h...

PharmatrophiX, Initially Funded by the Alzheimer's Drug Discovery Foundation, Announces Exclusive Global Collaboration with Elan

... says Dr. Fillit. "At ADDF, we are about results - bridging the gap between basic research and later stage drug development in humans. Alzheimer's is t... ADDF uses a venture philanthropy model to bridge the worldwide funding gap between basic research and later-stage development, using any return on investment ...

China Sky One Medical, Inc. Appoints New Independent Director

...i Lee has been a Managing Director with Transworld Capital Group, a U.S. investment service firm specializing in cross-border M&A and fund raising between U.S. and China. In 2008, he served as Chief Operating Officer (on loan) for Legend Media Corporation, a U.S.-listed company specializing in radio adve...

Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009

...mately 15% as compared to the second quarter of 2008 and 4% as compared to the first quarter of 2009. Excluding the impact of foreign currency changes between the respective periods, the revenue growth figures indicated above would have been 21% and 3%, respectively. Base Medical Products. Certain of ou...